xSPECT-based Myocardial Perfusion Scintigraphy: Consistency of Functional Values and Feasibility of Myocardial Uptake Quantitation in Patients With Suspected Coronary Artery Disease

NCT04583787 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2024-06-28

No results posted yet for this study

Summary

This study is to evaluate the feasibility of myocardial Standardized Uptake Volume (SUV) assessment by means of X- (Single photon emission tomography) SPECT/Computed tomography (CT), to assess normal reference value under rest and stress in a homogeneous population without Coronary Artery Disease (CAD) and to assess the variation of absolute quantitative SUV measurements under rest and stress. The values will be evaluated in comparison with perfusion Positron Emission Tomography (PET)/CT (using 82Rb as perfusion tracer) and CT coronary angiography (CTCA) with contrast medium.).

Conditions

Interventions

DIAGNOSTIC_TEST

99mTc-sestamibi myocardial perfusion SPECT

82Rb-PET/CT with CT based coronary angiography (CCTA) as part of clinical care at Day 1

DIAGNOSTIC_TEST

82Rb-Chloride myocardial perfusion PET with CCTA

stress-rest 99mTc-sestamibi myocardial perfusion SPECT, performed subsequent to 99mTc-sestamibi myocardial perfusion SPECT at Day 2

Sponsors & Collaborators

  • Siemens Corporation, Corporate Technology

    collaborator INDUSTRY
  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Federico Caobelli, Dr. med. · Clinic of Radiology & Nuclear Medicine

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-07
Primary Completion
2024-05-28
Completion
2024-05-28

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04583787 on ClinicalTrials.gov